Julia Beaver, MD

Dr. Julia A. Beaver is the Chief of Medical Oncology in the Oncology Center of Excellence at the U.S. Food and Drug Administration (FDA) and Deputy Director (acting) in the Office of Oncologic Diseases in the Center for Drug Evaluation and Research at FDA. She was previously the Director of the Division of Oncology 1. Prior to serving as Division Director, she was Breast Cancer Team Leader and then Supervisory Associate Division Director. Through her time at FDA, she has spearheaded the authorship of multiple FDA Guidances for Industry including guidances related to expansion of eligibility criteria, male breast cancer, placebos and blinding, and metastasis-free survival.

Dr. Beaver has also published multiple regulatory research projects and co-leads the OOD/OBP Next Generation Sequencing Translational Research Laboratory. She serves on the Liquid Biopsy Blood Profiling Atlas in Cancer (Blood-PAC) committee and has particular expertise in Precision Oncology. Dr. Beaver also is an Assistant Professor of Oncology, part-time, at Johns Hopkins University where she is a member of the Johns Hopkins Breast Cancer Group. Dr. Beaver graduated magna cum laude from Princeton University and then earned her medical degree from the University of Pennsylvania School of Medicine. She completed a residency in Internal Medicine at Johns Hopkins University School of Medicine, followed by a fellowship in Medical Oncology at The Johns Hopkins Sidney Kimmel Cancer Center.